Related Experiment Video
Updated: Jul 27, 2026
06:15
A Modified Trier Social Stress Test for Vulnerable Mexican American Adolescents
Published on: July 10, 2017
Serial dexamethasone suppression tests in male chronic schizophrenic patients
The American Journal of Psychiatry
|July 1, 1984
Summary
This study monitored dexamethasone suppression tests in five male schizophrenia patients over 12 weeks. Some patients showed nonsuppression, indicating potential HPA axis dysregulation in chronic schizophrenia.
Area of Science:
- Neuroscience
- Psychiatry
- Endocrinology
Background:
- Schizophrenia is a complex psychiatric disorder.
- The hypothalamic-pituitary-adrenal (HPA) axis may be dysregulated in schizophrenia.
- The dexamethasone suppression test (DST) is a tool to assess HPA axis function.
Purpose of the Study:
- To investigate the frequency of dexamethasone nonsuppression in male patients with chronic schizophrenia.
- To assess the utility of serial DSTs in this patient population.
Main Methods:
- Weekly dexamethasone suppression tests were administered over 12 weeks.
- The study included five male patients diagnosed with chronic schizophrenia.
- Patients were nondepressed.
Main Results:
- Nonsuppression of the dexamethasone test was observed in all five patients.
- Two patients exhibited three instances of nonsuppression.
- Two patients showed two instances of nonsuppression, and one patient had one instance.
Conclusions:
- Dexamethasone nonsuppression is a recurring finding in some male patients with chronic schizophrenia.
- Serial DSTs may reveal intermittent HPA axis dysregulation in schizophrenia.
- Further research is warranted to explore the clinical implications of these findings.
